Ligand · T62
T62 · 5-(2-amino-[1,2,4]triazolo[1,5-c]quinazolin-5-ylmethyl)-benzene-1,3-diol
T62, 5-(2-amino-[1,2,4]triazolo[1,5-c]quinazolin-5-ylmethyl)-benzene-1,3-diol (C16 H13 N5 O2, 307.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…
- Component
- T62
- Formula
- C16 H13 N5 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
T62 in 2 structures; the first of them:
- 4CWO · Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor · T62 A1226 · binds LEU48, ASN51, SER52, ALA55, ASP93, MET98, LEU103, LEU107 and 7 more
- 4CWO · Human HSP90 alpha N-terminal domain in complex with an aminotriazoloquinazoline inhibitor · T62 A1226 · binds LEU48, ASN51, SER52, ALA55, ASP93, MET98, LEU103, LEU107 and 7 more
Residues it binds most
LEU 2, VAL 2, ALA 2, ASN 2, ASP 2, GLY 2, MET 2, PHE 2, SER 2, THR 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.